Mit einer gepoolten Datenanalyse wurde erstmals die Sicherheit und Wirksamkeit von Nivolumab als Monosubstanz und in Kombination mit Ipilimumab beim seltenen, hochaggressiven Schleimhautmelanom untersucht.
http://ift.tt/2pIZ9cV
http://ift.tt/2rgTmLG
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
An advanced spatio-temporal model for particulate matter and gaseous pollutants in Beijing, China Publication date: 15 August 2019 Source: ...
-
Acquired olfactory dysfunction in children and adolescents - a systematic review of the literature. Chem Senses. 2018 Jul 18;: Author...
-
Publication date: May 2017 Source: Neuroimaging Clinics of North America, Volume 27, Issue 2 http://ift.tt/2pfyuQ5 http://ift.tt/2...
-
Publication date: March 2017 Source: World Neurosurgery, Volume 99 Author(s): Je Il Ryu, Koang Hum Bak, Jae Min Kim, Hyoung-Joon Chun Ba...
-
Publication date: May 2017 Source: The Kaohsiung Journal of Medical Sciences, Volume 33, Issue 5 http://ift.tt/2pFwvby http://ift....
-
Publication date: Available online 2 August 2017 Source: Annals of Allergy, Asthma & Immunology Author(s): Bernardo Sousa-Pinto, João ...
-
J Med Case Rep. Mandibular intraosseous pseudocarcinomatous hyperplasia: a case report. Fuchs A1, Hartmann S2, Ernestus K3, Mutzbauer G3, ...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου